Active Ingredient(s): Cabazitaxel
FDA Approved: * June 17, 2010
Pharm Company: * SANOFI AVENTIS US
Category: Cancer

Cabazitaxel, sold under the brand name Jevtana, is a semi-synthetic derivative of a natural taxoid.[2] It is a microtubule inhibitor,[1] and the fourth taxane to be approved as a cancer therapy.[citation needed] Cabazitaxel was developed by Sanofi-Aventis and was approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone-refractory prostate cancer in June 2010.[3][4][5] It... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Jevtana Kit
NDC: 0024-5824
Sanofi-aventis U.S. LLC

Popular Topics

Jevtana and shortness of breath

I have received at least four Jevtana infusions and my onconologist is letting me rest now. I have many of the side effe...

Jevtana Reviews

I have had Jevtana every 3 weeks since October 2010. My last dose on Monday the 30th of January is by far the worse. Hav...